Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Disease: 12Ingredient: 12Target: 1Links: 24
Arranging relationship network...
Record Fields
Scalar fields from the final target record.
- Target Id
- 2775
- Core Entity Id
- Source Entity Count
- 4
- Preferred Name
- NT5E
- Name Cn
- Name Pinyin
- Name En
- 5'-nucleotidase ecto
- Name Latin
- Bilingual Status
- partial
- Chromosome
- 6
- Map Location
- 6q14.3
- Type Of Gene
- protein-coding
- Organism
- Homo sapiens
- Taxonomy Id
- 9606
- Ttd Target Type
- Clinical Trial target
Names
Preferred names, aliases, and source labels retained in the final schema.
Name
NT5E
Role
gene_symbol
Source
HERB_v2
Preferred
Yes
Name
5'-nucleotidase ecto
Role
protein_name
Source
HERB_v2
Preferred
No
Name
CALJA
Role
alias
Source
HERB_v2
Preferred
No
Name
CD73
Role
alias
Source
HERB_v2
Preferred
No
Name
E5NT
Role
alias
Source
HERB_v2
Preferred
No
Name
NT
Role
alias
Source
HERB_v2
Preferred
No
Name
NT5
Role
alias
Source
HERB_v2
Preferred
No
Name
NTE
Role
alias
Source
HERB_v2
Preferred
No
Name
eN
Role
alias
Source
HERB_v2
Preferred
No
Name
eNT
Role
alias
Source
HERB_v2
Preferred
No
Name
5'-nucleotidase Ecto
Role
gene_name
Source
SymMap_v2
Preferred
No
Name
5'-nucleotidase
Role
protein_name
Source
SymMap_v2
Preferred
No
Name
5'-nucleotidase, ecto (CD73)
Role
protein_name
Source
TCMBank
Preferred
No
Cross References
Trusted external identifiers retained for this final record.
Hit
T0395
Pdb
4H1S|4H1Y|4H2B|4H2F|4H2G|4H2I
Ttd
T65116
Herb
HBTAR002775
Hgnc
8021
Omim
129190
Vega
OTTHUMG00000015139
Entrez
49072397
Sym Map
SMTT02397
Ensembl
ENSG00000135318
Uni Prot
P21589
Gen Bank Gene
X55740
Tcmbank Target
243912517
Gen Bank Protein
23897.0
Attributes
Merged source attributes and domain-specific metadata.
Version
v1,v2
Organism
Homo sapiens
Suppress
0
Chromosome
6
Taxonomy Id
9606
Map Location
6q14.3
Type Of Gene
protein-coding
Ttd Target Type
Clinical Trial target